Instead, the posttranslational modifications of cell cycle regulators and the estrogen receptor α (ERα), as well as other breast cancer-related proteins, support an additional tumor-suppressive role of BRCA1/BARD1 [23]. The gene discussed is ESR1; the disease is neoplasm.